Stay updated on Pembrolizumab in Advanced Sarcomas Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Sarcomas Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Sarcomas Clinical Trial page
- Check4 days agoChange DetectedNo substantive changes to the study details were detected; arms, eligibility criteria, outcomes, and locations appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check11 days agoNo Change Detected
- Check33 days agoChange DetectedNew operating-status notice and version update to v3.2.0 are now present, replacing the previous v3.1.0; this adds important information about potential funding-related service limitations and where to check for status.SummaryDifference3%

- Check40 days agoChange DetectedUpdated taxonomy: broader bone-related disease categories added; several specific terms removed; software revision bumped to v3.1.0.SummaryDifference0.7%

- Check54 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed. Overall core content remains unchanged.SummaryDifference0.2%

- Check61 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.2%

- Check69 days agoChange DetectedThe web page has undergone significant updates, including the addition of specific facility names and locations related to soft tissue sarcoma treatment, while also removing some redundant location terms and classifications.SummaryDifference2%

Stay in the know with updates to Pembrolizumab in Advanced Sarcomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Sarcomas Clinical Trial page.